Pipeline
We are advancing a robust pipeline by employing S-nitrosylation scientific expertise to prosecute novel targets from our discovery platform with our proprietary drug discovery engine. SNO bio’s pipeline creates value and addresses serious medical conditions in new ways.
Targets can be accessed by all standard drug modalities.
We are advancing a robust pipeline of novel SNO therapeutics
Based on the proportion of the proteome that is S-nitrosylated, there will be hundreds of enzymatic targets. Even after using our first mover advantage to fill our internal pipeline, there still will be enormous unrealized potential from our platform. Partnering with experts in a given therapeutic area or drug modality will be integral to maximizing the potential of our platform for patients. Our aim is to empower partners with a rapid, efficient approach to targeting the diseases that matter most to them.
